Advances in Hematological Malignancies
Recent years have witnessed remarkable progress in the domain of hematological malignancies. Novel approaches such as targeted agents, immunotherapies, and gene editing are revolutionizing the prognosis for patients with blood cancers. Clinical trials continue to explore these innovative techniques, offering hope for more curative treatment options